PUBLISHER: KBV Research | PRODUCT CODE: 1472500
PUBLISHER: KBV Research | PRODUCT CODE: 1472500
North America Inhalation Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin Capsules, and Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, and Others), By Country and Growth Forecast, 2024 - 2031
The North America Inhalation Capsules Market would witness market growth of 5.1% CAGR during the forecast period (2024-2031).
The US market dominated the North America Inhalation Capsules Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $332.8 Million by 2031. The Canada market is experiencing a CAGR of 7.5% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 6.6% during (2024 - 2031).
Asthma, COPD, and cystic fibrosis are among the respiratory diseases whose prevalence continues to increase due to air pollution, smoking, and an aging population. As per the World Health Organization, chronic obstructive pulmonary disease accounted for 3.23 million fatalities in 2019, placing it as the third leading cause of death. The majority of COPD-related fatalities among individuals aged 70 and below transpire in low and middle-income nations (LMIC). As a result, a growing population requires ongoing management and treatment for respiratory conditions, which drives the demand for inhalation capsules.
Additionally, household air pollution exposure leads to noncommunicable diseases, including stroke, ischemic heart disease, chronic obstructive pulmonary disease (COPD), and lung cancer. Women and children, typically responsible for household chores such as cooking and collecting firewood, bear the greatest health burden from using polluting fuels and technologies in homes. More than 237,000 children under the age of five perished annually due to household air pollution in 2020, according to estimates.
The prevalence of asthma in North America has been on the rise, affecting millions of individuals across the continent. For example, according to the Centers for Disease Control and Prevention (CDC), the percentage of adults aged 18 and older who had asthma was 8.7% in 2022. According to the Department of Health of New York State, in 2021, an estimated 1.4 million adults and over 315,000 children had asthma. Hence, the increasing prevalence of asthma in North America is driving the demand for inhalation therapy, further aiding in the growth of the inhalation capsules market.
Based on Type, the market is segmented into Gelatin Capsules, and Hypromellose Capsules. Based on Application, the market is segmented into Asthma Treatment, COPD Management, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Cipla Limited
- Novartis AG
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Lonza Group Ltd. (Capsugel)
- Chiesi Farmaceutici S.p.A
- Vectura Group Plc (Philip Morris International, Inc.)
- Elpen S.A.
- Healthcaps India Ltd.
- Qualicaps Co., LTD. (Roquette Freres SA)
North America Inhalation Capsules Market Report Segmentation
By Type
- Gelatine Capsules
- Hypromellose Capsules
By Application
- Asthma Treatment
- COPD Management
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1North America Inhalation Capsules Market, by Type
- 1.4.2North America Inhalation Capsules Market, by Application
- 1.4.3North America Inhalation Capsules Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
- 3.3Porter's Five Forces Analysis
Chapter 4.Recent Strategies Deployed in Inhalation Capsules Market
Chapter 5.North America Inhalation Capsules Market by Type
- 5.1North America Gelatin Capsules Market by Region
- 5.2North America Hypromellose Capsules Market by Region
Chapter 6.North America Inhalation Capsules Market by Application
- 6.1North America Asthma Treatment Market by Country
- 6.2North America COPD Management Market by Country
- 6.3North America Others Market by Country
Chapter 7.North America Inhalation Capsules Market by Country
- 7.1US Inhalation Capsules Market
- 7.1.1US Inhalation Capsules Market by Type
- 7.1.2US Inhalation Capsules Market by Application
- 7.2Canada Inhalation Capsules Market
- 7.2.1Canada Inhalation Capsules Market by Type
- 7.2.2Canada Inhalation Capsules Market by Application
- 7.3Mexico Inhalation Capsules Market
- 7.3.1Mexico Inhalation Capsules Market by Type
- 7.3.2Mexico Inhalation Capsules Market by Application
- 7.4Rest of North America Inhalation Capsules Market
- 7.4.1Rest of North America Inhalation Capsules Market by Type
- 7.4.2Rest of North America Inhalation Capsules Market by Application
Chapter 8.Company Profiles
- 8.1Cipla Limited
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5SWOT Analysis
- 8.2Novartis AG
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expense
- 8.2.5Recent strategies and developments:
- 8.2.5.1Trials and Approvals:
- 8.2.6SWOT Analysis
- 8.3AstraZeneca PLC
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Regional Analysis
- 8.3.4Research & Development Expenses
- 8.3.5Recent strategies and developments:
- 8.3.5.1Partnerships, Collaborations, and Agreements:
- 8.3.5.2Trials and Approvals:
- 8.3.6SWOT Analysis
- 8.4Boehringer Ingelheim International GmbH
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Regional & Segmental Analysis
- 8.4.4Research & Development Expenses
- 8.4.5SWOT Analysis
- 8.5Lonza Group Ltd. (Capsugel)
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expenses
- 8.5.5SWOT Analysis
- 8.6Chiesi Farmaceutici S.p.A
- 8.6.1Company Overview
- 8.6.2Recent strategies and developments:
- 8.6.2.1Partnerships, Collaborations, and Agreements:
- 8.6.2.2Product Launches and Product Expansions:
- 8.6.3SWOT Analysis
- 8.7Vectura Group plc (Philip Morris International, Inc.)
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Regional Analysis
- 8.7.4Research & Development Expenses
- 8.7.5Recent strategies and developments:
- 8.7.5.1Partnerships, Collaborations, and Agreements:
- 8.7.5.2Geographical Expansions:
- 8.7.6SWOT Analysis
- 8.8Elpen S.A.
- 8.8.1Company Overview
- 8.8.2SWOT Analysis
- 8.9Healthcaps India Ltd.
- 8.9.1Company Overview
- 8.9.2SWOT Analysis
- 8.10.Qualicaps Co., LTD. (Roquette Freres SA)
- 8.10.1Company Overview
- 8.10.2SWOT Analysis
LIST OF TABLES
- TABLE 1North America Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 2North America Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 3North America Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 4North America Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 5North America Gelatin Capsules Market by Region, 2020 - 2023, USD Million
- TABLE 6North America Gelatin Capsules Market by Region, 2024 - 2031, USD Million
- TABLE 7North America Hypromellose Capsules Market by Region, 2020 - 2023, USD Million
- TABLE 8North America Hypromellose Capsules Market by Region, 2024 - 2031, USD Million
- TABLE 9North America Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 10North America Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 11North America Asthma Treatment Market by Country, 2020 - 2023, USD Million
- TABLE 12North America Asthma Treatment Market by Country, 2024 - 2031, USD Million
- TABLE 13North America COPD Management Market by Country, 2020 - 2023, USD Million
- TABLE 14North America COPD Management Market by Country, 2024 - 2031, USD Million
- TABLE 15North America Others Market by Country, 2020 - 2023, USD Million
- TABLE 16North America Others Market by Country, 2024 - 2031, USD Million
- TABLE 17North America Inhalation Capsules Market by Country, 2020 - 2023, USD Million
- TABLE 18North America Inhalation Capsules Market by Country, 2024 - 2031, USD Million
- TABLE 19US Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 20US Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 21US Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 22US Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 23US Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 24US Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 25Canada Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 26Canada Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 27Canada Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 28Canada Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 29Canada Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 30Canada Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 31Mexico Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 32Mexico Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 33Mexico Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 34Mexico Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 35Mexico Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 36Mexico Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 37Rest of North America Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 38Rest of North America Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 39Rest of North America Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 40Rest of North America Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 41Rest of North America Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 42Rest of North America Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 43Key Information - Cipla Limited
- TABLE 44Key Information - Novartis AG
- TABLE 45Key Information - AstraZeneca PLC
- TABLE 46Key Information - Boehringer Ingelheim International GmbH
- TABLE 47Key Information -Lonza Group Ltd.
- TABLE 48Key Information - Chiesi Farmaceutici S.p.A
- TABLE 49Key Information - Vectura Group plc
- TABLE 50Key Information - Elpen S.A.
- TABLE 51Key Information - Healthcaps India Ltd.
- TABLE 52Key Information - Qualicaps Co., LTD.
